Low molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics.
Freedman
M D
MD
New York Medical College, Valhalla.
D002986:Clinical Trials as Topic; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight